Very hard

Why is carbidopa combined with levodopa in the treatment of Parkinson disease?

Correct answer: B. It reduces peripheral conversion of levodopa to dopamine

  • A. It blocks dopamine receptors in the basal ganglia
  • B. It reduces peripheral conversion of levodopa to dopamine
  • C. It prevents all involuntary movements caused by levodopa
  • D. It directly replaces acetylcholine in skeletal muscle

Explanation

Carbidopa inhibits peripheral conversion of levodopa to dopamine, allowing more levodopa to reach the brain and reducing peripheral adverse effects such as nausea. It does not block dopamine receptors or guarantee prevention of dyskinesias.

Submitted by a TestUstad contributor and published by the TestUstad editorial teamLast updated
Report an error

The more specific you are, the faster it gets fixed. A source beats an opinion.

Prefer email? support@testustad.com

About Analgesics and CNS Drugs

This area covers opioid and non-opioid analgesics, local anaesthetics, sedatives, anxiolytics, antidepressants, antipsychotics, antiepileptics and drugs for Parkinsonism. It examines therapeutic actions, dependence, respiratory depression, extrapyramidal effects, serotonin related toxicity and the distinction between pain relief, sedation and loss of consciousness.

Practise Analgesics and CNS Drugs

50 free Analgesics and CNS Drugs MCQs from Nursing Pharmacology, each with the correct answer and an explanation. Unlimited attempts, no account needed.

Discussion

Stuck on an option, or know a faster way to get there? Ask or explain it here.

No comments yet. Be the first to explain this one.

Exams that ask Nursing Pharmacology questions like this

Nursing Pharmacology is on 8 papers prepared for on TestUstad, and all of them draw the same bank, so this question is worth knowing for every one of them.

More Analgesics and CNS Drugs questions